Announcements

We are pleased to announce the launch of a new initiative—the MDPI Special Issue Mentor Program.

This program will enable early career researchers (who must hold a Ph.D. in a related field) to experience editing a Special Issue in MDPI journals, under the mentorship of our experienced Editorial Board Members or other experienced scientists. The mentor program will provide an excellent opportunity for early career scientists to gain editorial experience, and to cultivate their ability to edit scientific research.

The mentee’s responsibilities include:

• Proposing a Special Issue title and assisting the mentor in preparing a summary (around 200–400 words) and 3–10 keywords describing the background, importance, and goal of the Issue;
• Writing a brief promotion plan for the Special Issue;
• Preparing a list of scholars who may be interested in the Issue and personally e-mailing invitations on behalf of Guest Editors;
• Writing an editorial for the online Special Issue together with the mentor.

The mentor’s responsibilities include:

• Conducting a final check before the Special Issue is published online;
• Performing editorial control of the Special Issue and quality control of the publications, both of which must be carried out in a timely manner;
• Providing suggestions to younger scholars if they have any doubts or concerns regarding submissions;
• Organizing video calls with young scholars and the Editorial Office regularly to discuss problems and improvement suggestions for the Special Issue;
• Making and submitting decisions regarding submissions with the assistance of mentees.

Certificates and awards:
After the Special Issue closes, the Editorial Office will provide official certificates for all the mentors and early career researchers.

If you are interested in this opportunity, please send your Special Issue proposal to the Editorial Office of a journal you choose, and we will discuss the process (i.e., mentor collaboration, Special Issue topic feasibility analysis, etc.) in further detail. The full list of MDPI journals is as follows: https://www.mdpi.com/about/journals.

In addition to the new Special Issue Mentor Program, we will continue to welcome all Special Issue proposals focusing on hot research topics.

The Current Oncology (ISSN: 1718-7729) editorial team is pleased to announce the launch of a new Section, “Oncology Nursing”. The aim of this Section is to publish high-quality manuscripts that will contribute to the work and education of oncology nurses. We are interested in manuscripts of relevance to oncology nursing care across the cancer trajectory (including prevention, diagnosis, treatment, rehabilitation, survivorship, end of life, and bereavement). All age groups, cancer types, and practice locations are relevant.

Manuscripts can have a focus on research, practice, education, administration, or policy. Topics could include but are not limited to the following:

• Care of inpatient, outpatient, or community-based populations;
• Care of individuals in rural and remote locations;
• Use of virtual approaches to provide oncology nursing care;
• Care for disadvantaged or marginalized populations;
• Symptom assessment and control;
• Patient education;
• Oncology nursing education;
• Innovations in oncology nursing care;
• Nurse-led approaches in oncology care;
• Fostering self-care management in cancer patients.

Prof. Dr. Margaret Fitch (University of Toronto, Canada) is serving as the Editor-in-Chief for this Section. We are currently recruiting Editorial Board Members, Guest Editors, and Topical Advisory Panel Members for this new Section. If you would like to build a platform to provide the scientific community in your area an opportunity to work on an interconnected set of papers on an innovative topic(s), please do not hesitate to join us.

You are welcome to apply to be a Guest Editor or join the Topical Advisory Panel at the following links:

• https://www.mdpi.com/journalproposal/sendproposalspecialissue/curroncol;
• https://www.mdpi.com/journal/curroncol/topical_advisory_panel_application.

Please do not hesitate to contact the Editorial Office (currentoncology@mdpi.com) for further details and clarification.

We look forward to receiving your proposals or submissions.

Current Oncology Editorial Office

MDPI has just become the first open access (OA) publisher to reach the milestone of one million articles published. That is one million articles freely available to all, to circulate and build upon! We are proud to share this special moment with the global scientific community.

This landmark has been reached thanks to the immeasurable support of more than 600,000 expert reviewers, 66,000 editorial board members and 6700 hard-working colleagues across MDPI’s global offices.

Within more than 25 years of publishing, our journals received 2.1 million manuscripts and generated 4.6 million peer review reports to get to one million papers published.

Reaching the milestone of one million articles published reinforces our mission to remove any existing barriers and to make scientific research accessible to all. Since its inception, MDPI’s goal has been to create reliable processes to make science open. This is a path towards facilitating the dissemination of novel insights in scientific communities.

Regular feedback from authors and reviewers shows that our service is greatly appreciated and needed. At the same time, the feedback helps us identify areas for further improvement.

As it stands, a significant share of published research findings remain closed access. More than half of the content published with the most well-known legacy publishers stays behind a paywall, and that is not including articles published in hybrid OA journals, or made available months or years after publication.

A new policy announced by the US administration in August 2022 requires that, as of January 2026, all US federally funded research be made freely and immediately available after publication. While the new policy does not mandate articles be published under an open access license, it is aligned with the open access movement in removing all barriers to research. Similarly, some of the most advanced research institutions in the world intend to have all funded research articles published in open access by 2025.

MDPI is proud to be the leading agent of the transition to open access.

"Thanks a Million" to all the contributors!

Recently, Clarivate^TM revealed its 2022 list of Highly Cited Researchers™—individuals at universities, research institutes, and commercial organizations.

The scientists who were selected for this year’s list of Highly Cited Researchers have published highly cited papers in the 11-year period from January 2011 to December 2021, with a citation frequency in the top 1% of academic subjects and the same year of publication in the Web of Science^TM database. Based on Web of Science Citation data, 6938 researchers from across the globe who have demonstrated a disproportionate level of significant and broad influence in their chosen field or fields over the last decade have been awarded Highly Cited Researcher 2022 designations. The list is truly global, spanning 69 countries or regions and spread across a diverse range of research sciences and social sciences.

According to statistics, Dr. Hiroji Iwata (Department of Breast Oncology, Aichi Cancer Center, Aichi, Japan), a member of the Editorial Board of Current Oncology (ISSN: 1718-7729), has been selected for the list of Highly Cited Researchers of Clarivate in 2022. He is being recognized for his high-quality scientific research achievements and outstanding contributions to professional fields. The Current Oncology journal office sincerely congratulates the elected Editorial Board Member and hopes that he continues to have an academically productive relationship with the journal.

Current Oncology (ISSN: 1718-7729) is an interdisciplinary, peer-reviewed, and open access journal published monthly online by MDPI. Articles published in the journal typically contain information that is directly relevant to clinical oncology practices, and have clear potential for applications in the current or future practices of cancer medicine. The journal is indexed within Scopus, SCIE (Web of Science), PubMed, MEDLINE, PMC, Embase, and other databases. For more details, please see the following link: https://www.mdpi.com/journal/curroncol/about.

The Current Oncology editorial team is pleased to announce this open call for Special Issue proposals, which offers a group of authors the opportunity to work on an interconnected set of papers on an innovative topic. We are soliciting high-quality proposals that will be evaluated in a continuous selection process throughout the year.

If you would like to propose a Special Issue topic for this journal, please contact the Current Oncology Editorial Office (currentoncology@mdpi.com) or complete and submit the form at the following link: https://www.mdpi.com/journalproposal/sendproposalspecialissue/curroncol. Our editors will respond to you as soon as possible.

The duties of acting as a Guest Editor are as follows:

• Refining the Special Issue’s title and scope, as well as providing a short introduction (100–200 words) and 5–10 keywords to set up the Special Issue’s website;
• Inviting contributors with the assistance of the in-house editor to achieve a publication target (e.g., 10 papers);
• Supervising the peer review process of the Special Issue, conducting a pre-review check, making final decisions based on at least two review reports that we have collected, etc.

The benefits of acting as a Guest Editor are as follows:

• As the Guest Editor, you will be offered an opportunity to publish one of your papers free of charge in an open access form, in addition to the chance to provide discounts to the papers that you invited for your Special Issue;
• A printed book of the Special Issue can be sent to you if more than 10 papers are published by the end of the Special Issue. See more information at https://www.mdpi.com/books;
• It is an ideal venue for networking and communicating with scholars in the research community, as well as a chance to mark you as influential within your discipline. The relationships you develop will last beyond the publication of your Special Issue, establishing a network for future collaboration.

The Editorial Office will set up the Special Issue’s website, arrange the promotional materials, assist with the invitations for paper contributions, and take care of the administrative tasks associated with peer review (including inviting reviewers, collating reports, contacting authors, and arranging professional production before publication).

Please do not hesitate to contact the Editorial Office (currentoncology@mdpi.com) for further details and clarification.

We look forward to receiving your proposals.

Current Oncology Editorial Office

We are pleased to announce that the website of the MDPI Sustainability Foundation has been revamped! For the past couple of months, our UX UI team and front-end developers have been working hard to launch the website in time for the opening of the Sustainability Awards nominations.

The website is not the only thing that has had a remodeling. Indeed, the format of the Emerging Sustainability Leader Award (ESLA) has been updated. ESLA is now a competition open to individual researchers or start-ups founded by researchers under the age of 35. Nominee applications will go through 2 rounds of selection until the final 3 are decided. The finalists will then be invited to give pitch presentations during the Award Ceremony to win either first place (10,000 USD) or runner-up (2 x 5000 USD).

The World Sustainability Award, on the other hand, remains the same: a total prize money of 100,000 USD is up for grabs by senior individual researchers or groups of researchers from the international research community.

Nominations for both the World Sustainability Award and the Emerging Sustainability Leader award are now open! Check out our new website for more information on how to nominate.

Peer Review Week began 19 September 2022 under the theme of “Research Integrity: Creating and Supporting Trust in Research”. Through various blog articles, podcast, and webinar, we discussed this crucial subject throughout the week, celebrating the essential role peer review plays in maintaining research quality.

To begin, we held a Webinar on the topic. Professor Peter W. Choate and Dr. Emmanuel Obeng-Gyasi joined Dr. Ioana Craciun, one of MDPI’s scientific officers, for an in-depth discussion.

We invite you to view the event recording:

During the week, the MDPI Blog in a series articles highlighted how good Peer Review safeguards research integrity. The following topics were covered:

• Peer Review Week 2022
• Research Integrity
• What We’ve Learned About Peer Review Reports
• 4 Steps to the Perfect Peer Review Report
• How to Write the Perfect Peer Review Report: An Interview
• Inviting Great Peer Reviewers

In a new edition of Insight Faster, an MDPI podcast, we were delighted to talk to the co-chairs of the Peer Review Week committee, Jayashree Rajagopalan (Senior Manager of Global Community Engagement for CACTUS) and Danielle Padula (Head of Marketing and Community Development at Scholastica) to get their take on this year’s event and its related topics.

You can find the Podcast here.

We hope you enjoy the contents!

We are now recruiting Reviewer Board Members (RBMs) for the journal Current Oncology (ISSN: 1718-7729). If you are an active researcher in the field and are passionate about publishing cutting-edge research, do not hesitate to contact the Current Oncology Editorial Office (currentoncology@mdpi.com).

Current Oncology is an international, peer-reviewed, and open access journal that represents a multidisciplinary medium encompassing health care workers in the field of cancer therapy to report upon and to review progress in the management of this disease. Current Oncology is indexed by Scopus, SCIE (Web of Science), PubMed, MEDLINE, PMC, Embase, and other databases. The 2021 Impact Factor of Current Oncology is 3.109, and the CiteScore is 3.5.

The benefits of joining our Reviewer Board are as follows:

• For each review, you will receive a discount voucher that can be used for reducing the article processing charge (APC) of a future submission to any MDPI journal;
• You may publish one paper per year with a 20% discount after standard peer-review in Current Oncology;
• You will be considered for the journal’s Outstanding Reviewer Award;
• You will receive a personalized reviewer certificate;
• You will have the ability to adjust your review frequency based on your schedule in our system;
• You can verify and showcase your peer-review and editorial contributions for our journal.

If you have any questions, suggestions, or recommendations, do not hesitate to let us know. We look forward to working with you.

Current Oncology Editorial Office

Current Oncology (ISSN: 1718-7729) is an international, peer-reviewed, open access journal on clinical oncology. It is published monthly online by MDPI.

To develop different research areas and continue to attract high-quality papers, Current Oncology is recruiting Section Editors-in-Chief (https://www.mdpi.com/journal/curroncol/sections) for the following Sections:

• “Gastrointestinal Oncology”;
• “Genitourinary Oncology”;
• “Palliative and Supportive Care”;
• “Dermato-Oncology”.

If you are an active researcher in one of the fields and are passionate about publishing cutting-edge research, please do not hesitate to contact us at currentoncology@mdpi.com. More information can be found on our homepage: https://www.mdpi.com/journal/curroncol.

Responsibilities of the Section Editor-in-Chief include the following:

• Deciding whether a manuscript should be accepted based on the reports we collect;
• Reviewing a small number of papers per year and managing the Section in collaboration with other editors;
• Promoting Current Oncology and increasing its visibility at academic conferences.

As a Section Editor-in-Chief, you have the opportunity to publish one paper per year free of charge in our journal. The term for this position is two years and can be renewed.

By combining our rigorous editorial policies with your expertise, we can maintain a high-quality journal. Thank you in advance for your interest. We look forward to collaborating with you soon.

Current Oncology Editorial Office

MDPI will be attending the 2022 CAGPO ACMOO Annual Conference, hosted by the 2022 CAGPO Annual Conference Committee, which will be held from 15 to 18 September 2022 in Toronto, Canada.

The CAGPO mission statement is to unify general practitioners in oncology, promote communication amongst general practitioners in oncology in tertiary care and primary care settings, act and speak as the recognized authority on behalf of and for the benefit of general practitioners in oncology and their interests, and promote the role of general practitioners in oncology within cancer centers and within the primary care setting. The conference is to address the learning needs of general practitioners in oncology (GPOs) and oncology-allied health attendees. During this meeting, we will address recent advancements in the standards of oncology care. Our speakers include GPOs, medical and radiation oncologists, as well as speakers from the disciplines of family medicine and clinical trials.

The following MDPI journals will be represented:

• Current Oncology (leading);
• Cancers;
• Medical Sciences;
• Pharmacy;
• Journal of Clinical Medicine;
• Cells;
• Onco.

If you are attending this conference, please feel free to start an on-site conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have.

For more information about the conference, please visit the following link: http://cagpo-annual-conference.ca, or contact the Current Oncology Editorial Office at curroncol@mdpi.com.